LMAT vs NVST
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
LMAT · LeMaitre Vascular$73.61 ▼ 1.67%
NVST · Envista Holdings$22.91 ▼ 1.55%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- LMAT -10.5%
- NVST +15.2%
Head to head
| Metric | LMAT | NVST |
|---|---|---|
| Price | $73.61 | $22.91 |
| Change today | ▼ 1.67% | ▼ 1.55% |
| Market cap | $1.68B | $3.67B |
| Return, 3 months | -10.1% | -16.2% |
| Return, year to date | -8.5% | +5.5% |
| Return, 1 year | -12.1% | +15.2% |
| P/E (TTM) | 26.8 | 6.0 |
| P/B | 3.9 | 1.2 |
| P/E percentile vs own 5y | 3rd | 30th |
| Dividend yield | 1.29% | – |
| Revenue growth (YoY, latest qtr) | +11.3% | +3.2% |
| Net profit growth (YoY) | -13.5% | +1,777.6% |
| Gross margin | 72.0% | 55.9% |
| Operating margin | 27.7% | 11.2% |
| Net margin | 23.5% | 22.0% |
| Return on equity | 15.6% | 20.5% |
| Analyst target vs. price | +38.6% | +31.4% |
| Analyst buy share | 75% | 58% |
| RSI (14) | 36 | 40 |
| 30-day volatility | 41.6% | 49.9% |
| Max drawdown, 1 year | -35.9% | -26.0% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- NVST is the largest of the group by market value.
- NVST has returned the most over the past year.
- NVST carries the lowest trailing P/E.
- LMAT is growing revenue fastest.
- LMAT keeps the most profit per dollar of sales.
- LMAT has been the calmest stock over the last 30 days.